Capricor Therapeutics CAPR
NASDAQ CAPR
$8.96 -0.51 (-5.39%)
As of: Oct 1, 2026 · 12:33 PM EDT

Capricor Therapeutics (CAPR) Other Non-Current Assets (2010 - 2026)

Updated

Capricor Therapeutics (CAPR) posted Other Non-Current Assets of $1.65 million for Q2 2026, up 224.1% from $508,002 a year earlier and up 7.3% from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Other Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Capricor Therapeutics' Other Non-Current Assets came in at $1.16 million, up 423.0% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 67.2% (FY2020 to FY2025).
  • In prior years, Capricor Therapeutics' Other Non-Current Assets was $221,700 in FY2024 (-17.3%), $268,172 in FY2023 (unchanged), $268,172 in FY2022 (-2.7%) and $275,722 in FY2021 (+210.8%).
  • The Q2 2026 figure stands as the highest quarterly Other Non-Current Assets in data going back to Q4 2010.
  • On a year-over-year basis, Other Non-Current Assets has increased in each of the last five quarters, with growth averaging 156.5% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q1 2026, with growth of 505.3%; the weakest was Q4 2024, with a decline of 17.3%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $1.53 million (Q1 2026), $1.16 million (Q4 2025) and $488,738 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Capricor Therapeutics 550.29 Mn 550.29 Mn - 1.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.65 Mn
Mar 31, 2026 1.53 Mn
Dec 31, 2025 1.16 Mn
Sep 30, 2025 488,738.00
Jun 30, 2025 508,002.00
Mar 31, 2025 253,374.00
Dec 31, 2024 221,700.00
Sep 30, 2024 319,246.00
Jun 30, 2024 319,558.00
Mar 31, 2024 293,722.00
Dec 31, 2023 268,172.00
Sep 30, 2023 268,172.00
Jun 30, 2023 268,172.00
Mar 31, 2023 268,172.00
Dec 31, 2022 268,172.00
Sep 30, 2022 268,172.00
Jun 30, 2022 268,172.00
Mar 31, 2022 275,722.00
Dec 31, 2021 275,722.00
Sep 30, 2021 288,701.00
API Access

Capricor Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CAPR&period=max&api_key=YOUR_API_KEY